Back
Global X SuperDividend REIT ETF Vs. Insmed, Inc. Industry Stock Comparison
Sell
32
SRET
Global X SuperDividend REIT ETF
Last Price:
$21.87
Seasonality Move:
-1.6%
Sell
50
INSM
Insmed, Inc.
Last Price:
$177.95
Seasonality Move:
4.92%
Sell
32
Global X SuperDividend REIT ETF (SRET)
is a Sell
Is Global X SuperDividend REIT ETF a Buy, Sell or Hold?
-
The current Global X SuperDividend REIT ETF [SRET] share price is $21.89. The Score for SRET is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
SRET is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Insmed, Inc. (INSM)
is a Sell
Is Insmed, Inc. a Buy, Sell or Hold?
-
The current Insmed, Inc. [INSM] share price is $177.88. The Score for INSM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
INSM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRET Stock Price Chart
What is Global X SuperDividend REIT ETF's stock price today?
-
The Global X SuperDividend REIT ETF share price today is $21.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRET is experiencing buying pressure, which is a positive indicator for future bullish movement.
INSM Stock Price Chart
What is Insmed, Inc.'s stock price today?
-
The Insmed, Inc. share price today is $177.88Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.
SRET Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.75 | Buy |
| Relative Strength Index (14 RSI): | 56.09 | Buy |
| Chaikin Money Flow: | 28926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.57 - 21.93) | Buy |
| Bollinger Bands (100): | (21.43 - 21.89) | Buy |
INSM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.24 | Sell |
| Relative Strength Index (14 RSI): | 40.43 | Sell |
| Chaikin Money Flow: | -130929 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (182.56 - 207.72) | Sell |
| Bollinger Bands (100): | (136.42 - 192.24) | Buy |
SRET Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.79 | Buy |
| 20-day SMA: | 21.77 | Buy |
| 50-day SMA: | 21.73 | Buy |
| 200-day SMA: | 21.21 | Buy |
| 8-day EMA: | 17.01 | Buy |
| 20-day EMA: | 9.86 | Buy |
| 50-day EMA: | 4.66 | Buy |
| 200-day EMA: | 1.27 | Buy |
INSM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 181.04 | Sell |
| 20-day SMA: | 192.98 | Sell |
| 50-day SMA: | 187.98 | Sell |
| 200-day SMA: | 123.73 | Buy |
| 8-day EMA: | 180.99 | Sell |
| 20-day EMA: | 187.7 | Sell |
| 50-day EMA: | 183.41 | Sell |
| 200-day EMA: | 137.61 | Buy |
Global X SuperDividend REIT ETF Earnings Growth & SRET Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Insmed, Inc. Earnings Growth & INSM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.47 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.77 per share, and an increase next year of $2.60 per share.
Global X SuperDividend REIT ETF Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Insmed, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||